Menu
GWAS Study

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.

Speedy HE, Di Bernardo MC, Sava GP et al.

24292274 PubMed ID
GWAS Study Type
11233 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SH
Speedy HE
DB
Di Bernardo MC
SG
Sava GP
DM
Dyer MJ
HA
Holroyd A
WY
Wang Y
SN
Sunter NJ
ML
Mansouri L
JG
Juliusson G
SK
Smedby KE
RG
Roos G
JS
Jayne S
MA
Majid A
DC
Dearden C
HA
Hall AG
MT
Mainou-Fowler T
JG
Jackson GH
SG
Summerfield G
HR
Harris RJ
PA
Pettitt AR
AD
Allsup DJ
BJ
Bailey JR
PG
Pratt G
PC
Pepper C
FC
Fegan C
RR
Rosenquist R
CD
Catovsky D
AJ
Allan JM
HR
Houlston RS
Chapter II

Abstract

Summary of the research findings

Genome-wide association studies (GWAS) of chronic lymphocytic leukemia (CLL) have shown that common genetic variation contributes to the heritable risk of CLL. To identify additional CLL susceptibility loci, we conducted a GWAS and performed a meta-analysis with a published GWAS totaling 1,739 individuals with CLL (cases) and 5,199 controls with validation in an additional 1,144 cases and 3,151 controls. A combined analysis identified new susceptibility loci mapping to 3q26.2 (rs10936599, P = 1.74 × 10(-9)), 4q26 (rs6858698, P = 3.07 × 10(-9)), 6q25.2 (IPCEF1, rs2236256, P = 1.50 × 10(-10)) and 7q31.33 (POT1, rs17246404, P = 3.40 × 10(-8)). Additionally, we identified a promising association at 5p15.33 (CLPTM1L, rs31490, P = 1.72 × 10(-7)) and validated recently reported putative associations at 5p15.33 (TERT, rs10069690, P = 1.12 × 10(-10)) and 8q22.3 (rs2511714, P = 2.90 × 10(-9)). These findings provide further insights into the genetic and biological basis of inherited genetic susceptibility to CLL.

1,739 European ancestry cases, 5,199 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

11233
Total Participants
GWAS
Study Type
Yes
Replicated
1,144 European ancestry cases, 3,151 European ancestry controls
Replication Participants
European
Ancestry
U.K., Sweden
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.